MXPA02011516A - Modelo de animal transgenico de trastornos neurodegenerativos. - Google Patents
Modelo de animal transgenico de trastornos neurodegenerativos.Info
- Publication number
- MXPA02011516A MXPA02011516A MXPA02011516A MXPA02011516A MXPA02011516A MX PA02011516 A MXPA02011516 A MX PA02011516A MX PA02011516 A MXPA02011516 A MX PA02011516A MX PA02011516 A MXPA02011516 A MX PA02011516A MX PA02011516 A MXPA02011516 A MX PA02011516A
- Authority
- MX
- Mexico
- Prior art keywords
- transgenic animal
- animal model
- neurodegenerative disorders
- well
- disease
- Prior art date
Links
- 238000011820 transgenic animal model Methods 0.000 title abstract 2
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 238000012512 characterization method Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
- A01K2267/0312—Animal model for Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
- A01K2267/0318—Animal model for neurodegenerative disease, e.g. non- Alzheimer's
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Eye Examination Apparatus (AREA)
Abstract
La presente invencion proporciona un modelo de animal transgenico de enfermedad de Alzheimer designado TgCRND8 asi como un metodo para preparar dicho modelo, que permite la caracterizacion de la etiologia de la enfermedad asi como el suministro de un sistema para el desarrollo y la prueba de tratamientos potenciales.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21253400P | 2000-06-20 | 2000-06-20 | |
PCT/CA2001/000900 WO2001097607A2 (en) | 2000-06-20 | 2001-06-19 | Transgenic animal model of neurodegenerative disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02011516A true MXPA02011516A (es) | 2005-07-01 |
Family
ID=22791418
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02011516A MXPA02011516A (es) | 2000-06-20 | 2001-06-19 | Modelo de animal transgenico de trastornos neurodegenerativos. |
Country Status (13)
Country | Link |
---|---|
EP (3) | EP1292187B1 (es) |
JP (3) | JP4938956B2 (es) |
AT (2) | ATE323408T1 (es) |
AU (1) | AU2001270377A1 (es) |
CA (1) | CA2407847C (es) |
CY (1) | CY1105122T1 (es) |
DE (2) | DE60118913T2 (es) |
DK (1) | DK1292187T3 (es) |
ES (1) | ES2262662T3 (es) |
MX (1) | MXPA02011516A (es) |
PT (1) | PT1292187E (es) |
SI (1) | SI1292187T1 (es) |
WO (1) | WO2001097607A2 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100994748B1 (ko) | 2002-04-19 | 2010-11-17 | 더 가버닝 카운실 오브 더 유니버시티 오브 토론토 | 알쯔하이머병의 치료를 위한 면역학적 방법 및 조성물 |
US7544855B2 (en) * | 2004-04-23 | 2009-06-09 | Buck Institute | Transgenic mouse whose genome comprises an APP having a mutation at amino acid 664 |
JP4590638B2 (ja) * | 2006-03-20 | 2010-12-01 | 国立大学法人鳥取大学 | 家族性筋萎縮性側索硬化症(fals)発症するトランスジェニックマウス |
CL2007002908A1 (es) | 2007-10-09 | 2008-05-30 | Univ Concepcion | Procedimiento electroquimico in vitro para evaluar capacidad neurotoxica de estructuras, principios activos y/o compuestos de interes en celulas vivas y que comprende medir y cuantificar los parametros electricos en membranas expuestas a dichos agreg |
CA2703727A1 (en) * | 2007-11-01 | 2009-05-07 | F. Hoffmann-La Roche Ag | Quadruple transgenic non-human animal |
WO2010054324A2 (en) * | 2008-11-10 | 2010-05-14 | The Regents Of The University Of Colorado, A Body Corporate | Methods for treating clinical conditions associated with lipoprotein lipase activity |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09507746A (ja) | 1993-10-27 | 1997-08-12 | アテナ ニューロサイエンシズ,インコーポレイティド | Swedish変異を有するAPP対立遺伝子を含有するトランスジェニック動物 |
JPH07132033A (ja) | 1993-11-12 | 1995-05-23 | Hoechst Japan Ltd | アルツハイマー病モデルトランスジェニック動物 |
ATE278023T1 (de) * | 1994-01-27 | 2004-10-15 | Univ Minnesota | Nicht humane, transgenische säugetiere mit sich entwickelnder neurologischer krankheit |
US5877399A (en) | 1994-01-27 | 1999-03-02 | Johns Hopkins University | Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease |
CA2221986A1 (en) * | 1995-06-07 | 1996-12-19 | Athena Neurosciences, Inc. | Method for identifying alzheimer's disease therapeutics using transgenic animal models |
US5894078A (en) | 1996-02-26 | 1999-04-13 | Advanced Bioconcept, Inc. | Transgenic mouse expressing C-100 app |
WO1999009150A1 (en) * | 1996-08-15 | 1999-02-25 | Bayer Corporation | Method of introducing modifications into a gene |
US5898094A (en) | 1996-10-21 | 1999-04-27 | University Of South Florida | Transgenic mice expressing APPK670N,M671L and a mutant presenilin transgenes |
TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
-
2001
- 2001-06-19 ES ES01949132T patent/ES2262662T3/es not_active Expired - Lifetime
- 2001-06-19 MX MXPA02011516A patent/MXPA02011516A/es not_active Application Discontinuation
- 2001-06-19 EP EP01949132A patent/EP1292187B1/en not_active Expired - Lifetime
- 2001-06-19 DK DK01949132T patent/DK1292187T3/da active
- 2001-06-19 CA CA2407847A patent/CA2407847C/en not_active Expired - Lifetime
- 2001-06-19 WO PCT/CA2001/000900 patent/WO2001097607A2/en active IP Right Grant
- 2001-06-19 AT AT01949132T patent/ATE323408T1/de not_active IP Right Cessation
- 2001-06-19 AT AT06007794T patent/ATE499832T1/de not_active IP Right Cessation
- 2001-06-19 DE DE60118913T patent/DE60118913T2/de not_active Expired - Lifetime
- 2001-06-19 EP EP10182160.1A patent/EP2263453B1/en not_active Expired - Lifetime
- 2001-06-19 PT PT01949132T patent/PT1292187E/pt unknown
- 2001-06-19 JP JP2002503093A patent/JP4938956B2/ja not_active Expired - Lifetime
- 2001-06-19 SI SI200130579T patent/SI1292187T1/sl unknown
- 2001-06-19 EP EP06007794A patent/EP1728423B1/en not_active Expired - Lifetime
- 2001-06-19 AU AU2001270377A patent/AU2001270377A1/en not_active Abandoned
- 2001-06-19 DE DE60144164T patent/DE60144164D1/de not_active Expired - Lifetime
-
2006
- 2006-07-19 CY CY20061101003T patent/CY1105122T1/el unknown
-
2009
- 2009-03-19 JP JP2009068078A patent/JP5070236B2/ja not_active Expired - Lifetime
-
2011
- 2011-06-14 JP JP2011132718A patent/JP2011172600A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DE60118913T2 (de) | 2007-01-25 |
WO2001097607A3 (en) | 2002-12-12 |
WO2001097607A2 (en) | 2001-12-27 |
JP4938956B2 (ja) | 2012-05-23 |
PT1292187E (pt) | 2006-07-31 |
ATE323408T1 (de) | 2006-05-15 |
EP1292187B1 (en) | 2006-04-19 |
EP1292187A2 (en) | 2003-03-19 |
JP2009178162A (ja) | 2009-08-13 |
JP5070236B2 (ja) | 2012-11-07 |
EP1728423A2 (en) | 2006-12-06 |
DK1292187T3 (da) | 2006-08-21 |
ES2262662T3 (es) | 2006-12-01 |
EP1728423A3 (en) | 2007-02-28 |
CY1105122T1 (el) | 2010-03-03 |
SI1292187T1 (sl) | 2006-10-31 |
JP2003535605A (ja) | 2003-12-02 |
ATE499832T1 (de) | 2011-03-15 |
EP2263453A1 (en) | 2010-12-22 |
EP2263453B1 (en) | 2018-06-13 |
DE60144164D1 (de) | 2011-04-14 |
EP1728423B1 (en) | 2011-03-02 |
DE60118913D1 (de) | 2006-05-24 |
JP2011172600A (ja) | 2011-09-08 |
AU2001270377A1 (en) | 2002-01-02 |
CA2407847A1 (en) | 2001-12-27 |
CA2407847C (en) | 2013-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE343792T1 (de) | Diagnostika und therapeutika für maculare degeneration | |
DK1287364T3 (da) | Diagnostisk og terapi til makulære degenerationsrelaterede lidelser | |
IL169889A0 (en) | Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin | |
WO2002079440A8 (en) | Transgenic mice containing gpcr5-1 gene disruptions | |
WO2002046390A3 (en) | Transgenic mice containing rptpb tyrosine phosphatase gene disruptions | |
MXPA02011516A (es) | Modelo de animal transgenico de trastornos neurodegenerativos. | |
WO2001087055A3 (en) | New screening tool for analyzing the behavior of laboratory animals | |
EP1254260A4 (en) | METHODS FOR DIAGNOSING AND TREATING A HEART DISEASE | |
DE60318065D1 (de) | Fcyriia-transgenes tiermodell für autoimmunkrankheit | |
ATE473009T1 (de) | Hemmung der neurodegeneration | |
WO2003028536A3 (en) | Methods for diagnosing and treating heart disease | |
WO2002048342A3 (en) | Knockout mice for trp6 gene | |
WO2002081658A8 (en) | Transgenic mice containing cacnb4 calcium ion channel gene disruptions | |
GB2351752B (en) | Under-reamed diaphragm walls | |
WO2002079433A3 (en) | Transgenic mice containing tmem3 beta-1,3-n-acetylglucosaminyltransferase gene disruptions | |
WO2002095054A3 (en) | Method of determining protein interaction inhibitors | |
WO2002079420A3 (en) | Adam-like protease disruptions, compositions and methods related thereto | |
WO2002048341A3 (en) | Knockout mice for a2d2 calcium ion channel subunit proteins | |
WO2002085094A3 (en) | Transgenic mice containing acylphosphatase gene disruptions | |
WO2002048346A3 (en) | Transgenic mice containing bsmap gene disruptions | |
BG106583A (en) | Diagnosis of a person's risk of developing alcoholism | |
WO2002045497A3 (en) | Transgenic mice containing dusp8 phosphatase gene disruptions | |
WO2002046391A3 (en) | Transgenic mice containing nori gene disruptions | |
WO2002045496A3 (en) | Transenic mice containing frp-rs4 gene disruptions | |
WO2003027227A3 (en) | Usp-3like deubiquitinating enzyme gene disruptions, compositions and methods related thereto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |